Add your professional email address below for verification
Who we are | We are a venture/growth focused firm with headquarters in NY and Boston, focusing on the intersection of life sciences and technology. |
Value add | Our co-founders have both been CEOs at unicorns, have founded over 30 companies and have been globally recognized for entrepreneurship and innovation. We have co-founded companies including Moderna, TripleLift (among the best cash raised to cash outcomes in NY tech history), Indigo Agriculture (CNBC Disruptor List), and many more unicorns. We understand how to run, operate and scale businesses. |
Firm type | VC |
Global HQ | 220 Riverside Blvd, New York, NY 10069 |
Branch office #1 | |
Branch office #2 | |
Branch office #3 | |
Branch office #4 | |
Branch office #5 |
Funding requirements | We invest in high performance healthcare companies at the convergence of technology and biology. We focus on 4 key themes: connectivity, platform innovation, payments and deep technology. This includes: distributed care, virtual care, wearables, patient empowerment, artificial intelligence, mental health and holistic care solutions, chronic disease management, data analysis, alternative drug pricing, value-based care, care efficiency, preventative medicine, synthetic biology, nanotechnology, personalized medicine, gene editing, and more |
Funding stages | 3. Early Revenue4. Scaling5. Growth |
Check size | $2M to $20M |
Target countries | ![]() ![]() ![]() ![]() |
This fund does not have a portfolio on OpenVC yet
How to get in touch | Email address |
Default email or URL to receive deal flow | |
CRM | |
https://www.linkedin.com/company/bedford-bridge | |
Website | https://www.bedfordbridge.com/ |
We invest in high performance healthcare companies at the convergence of technology and biology. We focus on 4 key themes: connectivity, platform innovation, payments and deep technology. This includes: distributed care, virtual care, wearables, patient empowerment, artificial intelligence, mental health and holistic care solutions, chronic disease management, data analysis, alternative drug pricing, value-based care, care efficiency, preventative medicine, synthetic biology, nanotechnology, personalized medicine, gene editing, and more